Noninvasive Tests of Liver Fibrosis and Their Combination in NAFLD: From Selected Patients to Real-Life Populations by J. Boursier & S. Francque
Noninvasive Tests of Liver Fibrosis and Their Combination
in NAFLD: From Selected Patients to Real-Life Populations
Submitted by Stéphanie Pinot on Wed, 10/16/2019 - 10:53
Titre Noninvasive Tests of Liver Fibrosis and Their Combination in NAFLD: From SelectedPatients to Real-Life Populations
Type de
publication Article de revue
Auteur Boursier, Jérôme [1], Francque, Sven [2]
Editeur Wiley
Type Article scientifique dans une revue à comité de lecture
Année 2019
Langue Anglais
Date 5 Août 2019
Numéro 5
Pagination 1500-1502
Volume 70
Titre de la
revue Hepatology
ISSN 1527-3350
Résumé en
anglais
Nonalcoholic fatty liver disease (NAFLD) has become extremely common, now
affecting 25% of the worldwide population. All physicians, regardless of their
specialty, are seeing NAFLD patients in their daily clinical practice, and all are
challenged by the identification of the small subgroup having an advanced form of
the disease. As with the other causes of chronic liver disease, it is now well
established that liver fibrosis is the main predictor of the prognosis in NAFLD,
justifying the interest in diagnosing fibrosis. Because it is not conceivable to perform
liver biopsy (currently the best reference, albeit imperfect, for liver fibrosis
evaluation) in large populations, noninvasive testing represents an attractive option
for the diagnosis and screening of NAFLD patients with advanced liver disease in
need of specialized management. The noninvasive tests currently available are mainly
represented by blood tests, either simple blood tests combining common indirect
markers of liver fibrosis or specialized blood tests, including direct markers of liver
fibrogenesis and fibrolysis, and elastography devices. This article is protected by
copyright. All rights reserved.
URL de la
notice http://okina.univ-angers.fr/publications/ua20347 [3]
DOI 10.1002/hep.30886 [4]
Lien vers le
document https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.30886 [5]
Autre titre Hepatology
Identifiant
(ID) PubMed 31381156 [6]
Liens
[1] http://okina.univ-angers.fr/jerome.boursier/publications
[2] http://okina.univ-angers.fr/publications?f%5Bauthor%5D=30406
[3] http://okina.univ-angers.fr/publications/ua20347
[4] http://dx.doi.org/10.1002/hep.30886
[5] https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.30886
[6] http://www.ncbi.nlm.nih.gov/pubmed/31381156?dopt=Abstract
Publié sur Okina (http://okina.univ-angers.fr)
